Recent News

• 06.16.2025 - June 16, 2025 - June 19, 2025 : 2025 BIO International Convention
• 04.15.2025 - Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
• 04.15.2025 - Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
• 04.11.2025 - 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.11.2025 - April 11, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.10.2025 - April 10, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 03.28.2025 - Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
• 03.28.2025 - Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
• 03.18.2025 - OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
• 03.17.2025 - OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

Recent Filings

• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.28.2025 - 8-K Current report
• 03.28.2025 - EX-99.1 EX-99.1
• 03.17.2025 - 8-K Current report
• 03.17.2025 - EX-99.1 EX-99.1